India Cattle Vaccine Market 2022-2030

    Multi User License - $2,999

    In Stock

    Coming Soon




    Additionally, the cattle sector has contributed the most to the expansion of the cattle vaccine industry in recent years.


    infographics; India Cattle Vaccine Market ,
India Cattle Vaccine Market  Size,
India Cattle Vaccine Market  Trends, 
India Cattle Vaccine Market  Forecast,
India Cattle Vaccine Market  Risks,
India Cattle Vaccine Market Report,
India Cattle Vaccine Market  Share


    The investment in cattle health will continue to be at the top of the agenda for policymakers.


    However, the companion cattle vaccine market, which primarily includes dogs and cats, is expanding at the fastest rate.


    In addition, majority of human rabies cases in India are transmitted by dogs, the government has consistently focused on the National Action Plan for Rabies, which aims to vaccinate all dogs in the country.


    Attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines are among the categories that make up the cattle vaccine market.


    The market is dominated by attenuated vaccines among these. The most prominent cattle vaccines are the Peste des petits ruminants (PPR) vaccine to combat goat plague, the Brucella vaccine to combat brucellosis, and the Foot and Mouth Disease (FMD) vaccine to protect cattle from FMD as a result of recent government initiatives under the National cattle Disease Control Programme.



    The government has set aside investment for the FMD vaccine program with the goal of containing the disease and eliminating it.


    The program aims to vaccinate all cattle, buffalo, sheep, goats, and pigs against FMD, as well as all bovine female calves between the ages of 4 and 8 months. Companies in the cattle vaccine industry have benefited greatly from new opportunities brought about by schemes like this one. 




    The India cattle vaccine market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.



    The indigenously developed vaccine developed by the Indian Council of Agricultural Research (ICAR) against the Lumpy Skin Disease (LSD) virus, which has resulted in the deaths of approximately 50,000 cattle in several states, is expected to be available for purchase in “four to five months.”


    The live attenuated vaccine, which was developed jointly by ICAR’s National Research Centre on Equines (NRCE) in Hisar, Haryana, and the Indian Veterinary Research Institute (IVRI) in Izatnagar, Uttar Pradesh, is similar to vaccines for tuberculosis, mumps, rubella, and measles.“


    It is also homologous, protecting cattle at 100 percent against LSD.At this time, they only administer vaccines against the goat pox and sheep pox viruses.


    Due to all three viruses belonging to the same genus of capripoxviruses, these heterologous vaccines only provide cattle with cross-protection (up to 70%) against LSD.





    1. What is the average cost per India cattle vaccine market right now and how will it change in the next 5-6 years?
    2. Average cost to set up an cattle vaccine market in India?
    3. How many India cattle vaccine market are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a India cattle vaccine market and key vendor selection criteria
    6. Where is the India cattle vaccine market  manufactured? What is the average margin per equipment?
    7. Market share of India cattle vaccine market manufacturers and their upcoming products
    8. The most important planned India cattle vaccine market in next 2 years
    9. Details on network of major India cattle vaccine market and pricing plans
    10. Cost advantage for OEMs who manufacture India cattle vaccine market in-house
    11. 5 key predictions for next 5 years in India cattle vaccine market
    12. Average B-2-B India cattle vaccine market price in all segments
    13. Latest trends in India cattle vaccine market, by every market segment
    14. The market size (both volume and value) of India cattle vaccine market in 2022-2030 and every year in between?
    15. Global production breakup of India cattle vaccine market, by suppliers and their OEM relationship




    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2030
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix


      Your Cart
      Your cart is emptyReturn to Shop